RUNX3 suppresses gastric epithelial cell growth by inducing p21 WAF1/CiP1 expression in cooperation with transforming growth factor β-activated SMAD

Molecular and Cellular Biology

Volumn 25, Issue 18, 2005, Pages 8097-8107

  Chi, Xin Zi ^a   Yang, Jeung Ook ^a   Lee, Kwang Youl ^a   Ito, Kosei ^b   Sakakura, Chohei ^c   Li, Qing Lin ^a   Kim, Hye Ryun ^a   Cha, Eun Jeung ^a   Lee, Yong Hee ^a   Kaneda, Atsushi ^d   Ushijima, Toshikazu ^d   Kim, Wun Jae ^a   Ito, Yoshiaki ^b   Bae, Suk Chul ^a  

^a Chungbuk National University   (South Korea)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; GENE PRODUCT; SMAD PROTEIN; TRANSCRIPTION FACTOR RUNX3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CDKN1A GENE; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; EPITHELIUM CELL; EPITHELIUM HYPERPLASIA; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NEWBORN; NONHUMAN; NULL ALLELE; P21 WAF1 CIP1 GENE; PRIORITY JOURNAL; PROMOTER REGION; RUNX3 GENE; SIGNAL TRANSDUCTION; STOMACH EPITHELIUM; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CYCLE PROTEINS; CORE BINDING FACTOR ALPHA 3 SUBUNIT; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; GASTRIC MUCOSA; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MICE; MUTATION; PROMOTER REGIONS (GENETICS); SMAD PROTEINS; STOMACH NEOPLASMS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 24344500170     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.18.8097-8107.2005     Document Type: Article

References (45)

1. Balmain, A. 2002. Cancer new-age tumour suppressors. Nature 417:235-237.
2. Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053-1061.
3. Datta, P. K., M. C. Blake, and H. L. Moses. 2000. Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-beta-induced physical and functional interactions between smads and Sp1. J. Biol. Chem. 275:40014-40019.
4. Derynck, R., R. J. Akhurst, and A. Balmain. 2001. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 29:117-129.
5. el Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
6. Goel, A., C. N. Arnold, P. Tassone, D. K. Chang, D. Niedzwiecki, J. M. Dowell, L. Wasserman, C. Compton, R. J. Mayer, M. M. Bertagnolli, and C. R. Boland. 2004. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers. Int. J. Cancer 112:754-759.
7. Guo, W. H., L. Q. Weng, K. Ito, L. F. Chen, H. Nakanishi, M. Tatematsu, and Y. Ho. 2002. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. Oncogene 21:8351-8355.
8. Hanai, J., L. F. Chen, T. Kanno, N. Ohtani-Fujita, W. Y. Kim, W. H. Guo, T. Imamura, Y. Ishidou, M. Fukuchi, M. J. Shi, J. Stavnezer, M. Kawabata, K. Miyazono, and Y. Ito. 1999. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Cα promoter. J. Biol. Chem. 274:31577-31582.
9. 1 cyclin-dependent kinases. Cell 75:805-816.
10. Inoue, K., S. Ozaki, T. Shiga, K. Ito, T. Masuda, N. Okado, T. Iseda, S. Kawaguchi, M. Ogawa, S. C. Bae, N. Yamashita, S. Itohara, N. Kudo, and Y. Ito. 2002. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat. Neurosci. 5:946-954.
11. Johnson, D. G., J. K. Schwarz, W. D. Cress, and J. R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349-352.
12. Rang, G. H., S. Lee, H. J. Lee, and K. S. Hwang. 2004. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. J. Pathol. 202:233-240.
13. Kim, T. Y., H. J. Lee, K. S. Hwang, M. Lee, J. W. Kim, Y. J. Bang, and G. H. Kang. 2004. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab. Investig. 84:479-484.
14. Ku, J. L., S. B. Kang, Y. K. Shin, H. C. Kang, S. H. Hong, I. J. Kim, J. H. Shin, I. O. Han, and J. G. Park. 2004. Promoter hypermethylation down-regulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene 23:6736-6742.
15. Lee, B., K. Thirunavukkarasu, L. Zhou, L. Pastore, A. Baldini, J. Hecht, V. Geoffroy, P. Ducy, and G. Karsenty. 1997. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat. Genet. 16:307-310.
16. Lee, M., J. Kwon, S. N. Kim, J. E. Kim, W. S. Koh, E. J. Kim, M. K. Chung, S. S. Han, and C. W. Song. 2003. cDNA microarray gene expression profiling of hydroxyurea, paclitaxel, and p-anisidine, genotoxic compounds with differing tumorigenicity results. Environ. Mol. Mutagen. 42:91-97.
17. Levanon, D., D. Bettoun, C. Harris-Cerruti, E. Woolf, V. Negreanu, R. Eilam, Y. Bernstein, D. Goldenberg, C. Xiao, M. Fliegauf, E. Kremer, F. Otto, O. Brenner, A. Lev-Tov, and Y. Groner. 2002. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 21:3454-3463.
18. Li, Q. L., K. Ito, C. Sakakura, H. Fukamachi, K. Inoue, X. Z. Chi, K. Y. Lee, S. Nomura, C. W. Lee, S. B. Han, H. M. Kim, W. J. Kim, H. Yamamoto, N. Yamashita, T. Yano, T. Ikeda, S. Itohara, J. Inazawa, T. Abe, A. Hagiwara, H. Yamagishi, A. Ooe, A. Kaneda, T. Sugimura, T. Ushijima, S. C. Bae, and Y. Ito. 2002. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109:113-124.
19. Li, Q. L., H. R. Kim, W. J. Kim, J. K. Choi, Y. H. Lee, H. M. Kim, L. S. Li, H. Kim, J. Chang, Y. Ho, L. K. Youl, and S. C. Bae. 2004. Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem. Biophys. Res. Commun. 314:223-228.
20. Look, A. T. 1997. Oncogenic transcription factors in the human acute leukemias. Science 278:1059-1064.
21. Lutterbach, B., J. J. Westendorf, B. Linggi, S. Isaac, E. Seto, and S. W. Hiebert. 2000. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J. Biol. Chem. 275:651-656.
22. Malliri, A., W. A. Yeudall, M. Nikolic, D. H. Crouch, E. K. Parkinson, and B. Ozanne. 1996. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events. Cell Growth Differ. 7:1291-1304.
23. Massague, J., S. W. Blain, and R. S. Lo. 2000. TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103:295-309.
24. Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322.
25. Moustakas, A., and D. Kardassis. 1998. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA 95:6733-6738.
26. Mundlos, S., F. Otto, C. Mundlos, J. B. Mulliken, A. S. Aylsworth, S. Albright, D. Lindhout, W. G. Cole, W. Henn, J. H. Knoll, M. J. Owen, R. Mertelsmann, B. U. Zabel, and B. R. Olsen. 1997. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773-779.
27. Okuda, T., J. van Deursen, S. W. Hiebert, G. Grosveld, and J. R. Downing. 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321-330.
28. Oshimo, Y., N. Oue, Y. Mitani, H. Nakayama, Y. Kitadai, K. Yoshida, Y. Ito, K. Chayama, and W. Yasui. 2004. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma. Pathobiology 71:137-143.
29. Otto, F., A. P. Thornell, T. Crompton, A. Denzel, K. C. Gilmour, I. R. Rosewell, G. W. Stamp, R. S. Beddington, S. Mundlos, B. R. Olsen, P. B. Selby, and M. J. Owen. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
30. Pardali, K., A. Kurisaki, A. Moren, P. ten Dijke, D. Kardassis, and A. Moustakas. 2000. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J. Biol. Chem. 275:29244-29256.
31. Park, K., S. J. Kim, Y. J. Bang, J. G. Park, N. K. Kim, A. B. Roberts, and M. B. Sporn. 1994. Genetic changes in the transforming growth factor beta (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA 91:8772-8776.
32. Polyak, K., M. H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
33. Seoane, J., H. V. Le, L. Shen, S. A. Anderson, and J. Massague. 2004. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117:211-223.
34. 1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
35. Somasundaram, K., H. Zhang, Y. X. Zeng, Y. Mouvras, Y. Peng, H. Zhang, G. S. Wu, J. D. Licht, B. L. Weber, and W. S. El Deiry. 1997. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389:187-190.
36. Taniuchi, I., M. Osato, T. Egawa, M. J. Sunshine, S. C. Bae, T. Komori, Y. Ito, and D. R. Littman. 2002. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111:621-633.
37. van Wijnen, A. J., G. S. Stein, J. P. Gergen, Y. Groner, S. W. Hiebert, Y. Ito, P. Liu, J. C. Neil, M. Ohki, and N. Speck. 2004. Nomenclature for Runt-related (RUNX) proteins. Oncogene 23:4209-4210.
38. Wada, M., S. Yazumi, S. Takaishi, K. Hasegawa, M. Sawada, H. Tanaka, H. Ida, C. Sakakura, K. Ito, Y. Ito, and T. Chiba. 2004. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines. Oncogene 23:2401-2407.
39. Westendorf, J. J., S. K. Zaidi, J. E. Cascino, R. Kahler, A. J. van Wijnen, J. B. Lian, M. Yoshida, G. S. Stein, and X. Li. 2002. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol. Cell. Biol. 22:7982-7992.
40. Wheeler, J. C., C. VanderZwan, X. Xu, D. Swantek, W. D. Tracey, and J. P. Gergen. 2002. Distinct in vivo requirements for establishment versus maintenance of transcriptional repression. Nat. Genet. 32:206-210.
41. Woolf, E., C. Xiao, O. Fainaru, J. Lotem, D. Rosen, V. Negreanu, Y. Bernstein, D. Goldenberg, O. Brenner, G. Berke, D. Levanon, and Y. Groner. 2003. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc. Natl. Acad. Sci. USA 100:7731-7736.
42. Xiao, W. H., and W. W. Liu. 2004. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J. Gastroenterol. 10:376-380.
43. Xiong, Y., G. J. Hannen, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.
44. Yamada, K., M. Matsuki, Y. Morishima, E. Ueda, K. Tabata, H. Yasuno, M. Suzuki, and K. Yamanishi. 1997. Activation of the human transglutaminase 1 promoter in transgenic mice: terminal differentiation-specific expression of the TGM1-lacZ transgene in keratinized stratified squamous epithelia. Hum. Mol. Genet. 6:2223-2231.
45. Yanagawa, N., G. Tamura, H. Oizumi, N. Takahashi, Y. Shimazaki, and T. Motoyama. 2003. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci. 94:589-592.